Subscribe to My Feed




Tell a Friend




  • Polls

    How Is My Site? / ¿Cómo es mi sitio web?

    View Results

    Loading ... Loading ...
  • Recent Comments:

  • New Pharmaceutical Labeling Rules Proposed in Brazil

    Friday, April 10th, 2009

    Brazil’s National Sanitary Vigilance Agency (ANVISA) is proposing changes in package labeling rules for pharmaceuticals sold in that country (as set out in ANVISA Resolution RDC 333/03) with a view to making pack labels more informative to consumers.  For example, the proposals released for public consultation (until 11 May) would make medicines with a sedative […]

    Share

    An Andean Medicines Policy

    Sunday, March 29th, 2009

    Last Friday the 30th Meeting of the Health Ministers of the Andean Area (RMSAA) agreed on other important health measures — a coordinated epidemiological surveillance system, joint plans to combat HIV/AIDS, protect health in border areas and to combat child malnutrition — but the one that caught my eye was the new Andean Medicines Policy.
    Not […]

    Share

    DR & Central America Agree on Common Health, Pharma Policies/Programs

    Saturday, January 31st, 2009

    It doesn’t get much attention outside this corner of Latin America and the Caribbean (LAC), but the annual Meeting of the Health Sector of Central America and the Dominican Republic (Reunión del Sector Salud de Centro América y República Dominicana – RESSCAD) is quietly doing important work to change health policy among its seven member […]

    Share

    An Affordable Anti-Malarial / Um medicamento para malária a preço mais acessível

    Wednesday, August 20th, 2008

    From Drugs for Neglected Diseases initiative (DNDi):
    Sanofi-aventis and DNDi welcome the Clinton Foundation announcement on ACTs and commit to providing fixed-dose combination “ASAQ” at equally low prices
    Sanofi-aventis and the non-profit Drugs for Neglected Diseases initiative (DNDi) welcome the agreement announced by Clinton Foundation HIV/AIDS Initiative (CHAI) to reduce the volatility and the price levels of […]

    Share

    The Need to Improve the Safety of Children’s Medicines

    Friday, September 28th, 2007

    Pharmacovigilance and medicine safety issues in children are relevant to everyone who has an interest in and cares about the health of children.
    In order to gain full marketing authorization, the law in most countries requires pharmaceutical firms to demonstrate that they have tested their medicines in healthy volunteers and patients for possible adverse effects.  These […]

    Share